Pharma News, Research & Solutions

At Biogen, we are committed to putting the weight of our business, our employees, and our collaboration partners to help close the disparity gap in clinical trials and access to healthcare.

Learn more about how we #BackTheFrontline by investing in innovators developing scalable solutions to COVID-19 from Johnson & Johnson Impact Ventures Chair Joe Wolk.

On July 1, Johnson & Johnson announced that the European Commission (EC) has granted Marketing Authorisation for its Janssen Pharmaceutical Companies’ Ebola vaccine regimen for the prevention of Ebola Virus Disease.

The Alexion Charitable Foundation, launched by Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in February 2020, has announced it has awarded a total of $1.1 million in initial grants that align with its Rare Belonging® focus. Rare Belonging seeks to...

Future lawyer and chronic illness advocate, Lauren Work is on a mission to change the narrative of MS and improve health outcomes for underrepresented women.

After receiving the green light from the FDA to move forward, Gilead is about to start trials of an inhaled version of remdesivir. We will screen healthy volunteers for Phase 1 trials this week and hope to begin studies in patients with COVID-19...

Along with the Society for Immunotherapy of Cancer we strive for a future #Immune2Cancer because to our team, cancer immunotherapy research is personal.

3BL Media has named Merck to its annual 100 Best Corporate Citizens ranking, recognizing outstanding environmental, social and governance (ESG) transparency and performance among the 1,000 largest, U.S. public companies.

Tomorrow I will have the distinct honor of participating in a panel discussion held by the Congressional Black Caucus Foundation where I will join experts examining the incredibly damaging impact of the COVID-19 pandemic on the Black community.

Cato Laurencin, M.D., Ph.D., a world-renowned physician and healthcare leader weighs in on how racism is a public health crisis and discusses the impact of recent protests in the midst of a pandemic